Patent Watch: Have the Biosimilar Floodgates Been Opened in the United States?
April 30, 2015
Partners Courtenay Brinckerhoff and Kristel Schorr contributed an article to Nature Reviews, “Patent Watch: Have the Biosimilar Floodgates Been Opened in the United States?” on April 30, 2015. The article discussed the first US Food and Drug Administration’s first approval of a biosimilar product and the regulatory hurdles products must clear before entering the US market.
Author(s)
Related Insights
May 30, 2025
Foley Career Perspectives
Foley Mental Health Month Program: Enhancing Performance Through High-Quality Connections
Foley & Lardner endeavors to create a high-performance culture that also prioritizes well-being — a culture where every member of the…
May 29, 2025
Manufacturing Industry Advisor
Foley Automotive Update
Analysis by Julie Dautermann, Competitive Intelligence Analyst Foley is here to help you through all aspects of rethinking your long-term…
May 29, 2025
Foley Viewpoints
Supreme Court Clarifies Scope of Federal Fraud Statutes in Connection with False DBE Reporting on Federally Funded Projects
On May 22, 2025, the U.S. Supreme Court issued a significant decision in Kousisis v. United States, affirming a six-year prison sentence for a contractor convicted of federal wire fraud for misrepresenting use of a disadvantaged business enterprise supplier on a project.